1MAKSIMOWICZ-MCKINNON K, CLARK T M, HOFFMAN G S. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients [J]. Arthritis Rheum, 2007, 56 (3): 1000-1009.
2VANOLI M, DAINA E, SALVARANI C, et al. Takayasu's arteritis: a study of 104 Italian patients[J]. Arthritis Rheum, 2005, 53 (1) : 100-107.
3DE FRANCISCIS S, SERRA R, LUONGO A, et al. The management of Takayasu' s arteritis : personal experience [ J]. Ann Vasc Surg, 2007, 21 (6) : 754-760.
4MOLLOY E S, LANGFORD C A, CLARK T M, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis : long-term follow-up [J]. Ann Rheum Dis, 2008, 67 (11) : 1567-1569.
5KARAGEORGAKI Z T, MAVRAGANI C P, PAPATHANASIOU M A, et al. Infliximab in Takayasu arteritis: a safe alternative? [ J ] Clin Rheumatol, 2007, 26 (6): 984-987.
6LARSSON K, NORDBORG C, MOSLEMI A R, et al. A Western blot and molecular genetic investigation of the estrogen receptor beta in giant cell arteritis[J]. Clin Exp Rheumatol, 2006, 24 (2 Suppl 41): S17-S19.
7NESHER G, BERKUN Y, MATES M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis [J]. Arthritis Rheum, 2004, 50 (4) : 1332-1337.
8SCHMIDT W A. Takayasu and temporal arteritis [J]. Front Neurol Neurosci, 2006, 21 : 96-104.
9MORO J A, ALMENAR L, MARTINEZ-DOLZ L, et al. Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation [J]. Transplant Proc, 2005, 40 (9) : 3034-3036.
10FIELDS C E, BOWER T C, COOPER L T, et al. Takayasu's arteritis: operative results and influence of disease activity[J]. J Vasc Surg, 2006, 43 (1) : 64- 71.
